Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Arch Dermatol. 2012 Mar;148(3):335-44. doi: 10.1001/archdermatol.2011.338. Epub 2011 Nov 21.

Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions.

Author information

  • 1Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.

Abstract

OBJECTIVE:

To investigate the usefulness of a novel marker for melanocytic proliferations.

DESIGN:

Using a novel monoclonal antibody against soluble adenylyl cyclase (sAC), various benign and malignant melanocytic proliferations were immunostained.

SETTING:

Weill Medical College of Cornell University dermatopathology laboratory.

MAIN OUTCOME MEASURES:

The results were qualitative, not quantifiable.

RESULTS:

The sAC immunostaining produced distinctive patterns that paralleled melanomagenesis. At one pole of the spectrum were benign nevi, including atypical nevi of special sites and recurrent nevi showing a distinct pattern of dotlike Golgi staining, while at the opposite pole was melanoma, in which many cells demonstrated an intense pannuclear expression pattern, often accompanied by loss of the Golgi expression pattern. Melanomas of lentigo maligna and acral lentiginous subtypes exhibited the most striking pannuclear expression, while nodular melanomas showed the least, although with supervening enhanced diffuse cytoplasmic expression. Loss of the Golgi expression pattern was a feature of malignant melanoma.

CONCLUSION:

The sAC expression pattern is complex but seems discriminatory, with distinctive and variable staining patterns according to the nature of the lesion biopsied.

PMID:
22105816
[PubMed - indexed for MEDLINE]
PMCID:
PMC3387488
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Write to the Help Desk